Nick McEntee, Executive Director, Head of UK GMP Operations at Quotient Sciences discusses strategies for flexible, on-demand manufacture of clinical trial materials (CTMs) with Contract Pharma.
Clinical trials are a critical component in drug development. They require complex and careful planning to be carried out at the highest standards. Manufacturing of clinical trial materials (CTMs), the products used in clinical studies, is one of the key challenges when designing the trials successfully.
Nick's article with Contract Pharma explores the importance of CTM manufacturing and outlines how flexible, on-demand processes improve clinical trial efficiency at Quotient Sciences.